All treatments
Treatment
Trodelvy 200 mg powder for concentrate for solution for infusion clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic exploratory (Phase II)
An open label, single-arm, phase 2 study of neoadjuvant sacituzumab govitecan, before radical cystectomy, for patients with muscle-invasive bladder cancer who cannot receive or refuse cisplatin-based chemotherapy
This study is looking at a new medicine called Trodelvy for people with a type of bladder cancer that has grown into the muscle of the bladder. It's for those who can't have or don't want standard chemotherapy. Researchers want to see if Trodelvy helps shrink the cancer before surgery.
For: Muscle-invasive bladder cancerItaly - Ongoing, recruitingTherapeutic use (Phase IV)
Open-label Rollover Study to Evaluate Long-Term Safety in Subjects with Metastatic Solid Tumors that are Benefiting from Continuation of Therapy with Sacituzumab Govitecan
This study looks at the long-term safety of a treatment called Trodelvy for people with advanced cancers that have spread. It aims to see how safe the drug is when used over a longer period in patients who are already doing well on it.
For: Metastatic solid tumorsSpain · Belgium · France